Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • In Sterling Biotech...

    In Sterling Biotech Case, Court Takes Note Of Chargesheet

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-05T10:00:32+05:30  |  Updated On 5 Oct 2018 10:00 AM IST
    In Sterling Biotech Case, Court Takes Note Of Chargesheet

    MUMBAI: A Delhi court took cognisance of a supplementary charge sheet in connection with the over Rs. 5,000 crore-bank loan fraud case involving Gujarat-based Sterling Biotech, against a man arrested for allegedly sending Rs. 25 lakh cash to a senior Congress leader's residence.


    The court, which had earlier issued open-ended non-bailable warrants against pharma firm's directors, including Chetan Jayantilal Sandesara and Nitin Jayantilal Sandesara, said prima facie there were enough evidence against the accused -- Ranjit Malik alias Johny -- to proceed against him.


    Read Also: Sterling Biotech case: Supplementary charge sheet filed


    Additional Sessions Judge Satish Kumar Arora issued production warrant for November 1 against Malik, who was arrested by the agency for allegedly sending Rs. 25 lakh through one Rakesh Chandra to the politician's residence in the national capital.


    An "open-ended NBW" does not carry a time limit for execution unlike non-bailable warrants (NBW).


    The Enforcement Directorate's Special Public Prosecutor Nitesh Rana, who filed the charge sheet on September 29 under the sections of the Prevention of Money Laundering Act (PMLA), told the court on Wednesday that report was filed along with all the required documents and explained the chain of proceeds of crime.


    Read Also: ED to File Charge Sheet Against Sterling Biotech in Bank Loan Fraud Case of Over Rs 5000 Crore


    He said the probe will still continue in the matter and supplementary charge sheet is likely to be filed.


    The charge sheet, filed through advocate A R Aditya, also named Delhi-based businessman Gagan Dhawan, arrested earlier in the case.


    Malik was allegedly a middleman for Dhawan. While Malik is currently in judicial custody, Dhawan is out on bail.


    Besides Sandesra brother, the court had also issued NBW against Chetan's wife Dipti Sandesara, also a director in the firm, and her brother Hiteshkumar Narendrabhai Patel.


    The open-ended NBWs were issued after ED told the court that the four accused were likely to have left the country.


    In its charge sheet, the ED had told the court that the directors of the firm, along with others, had taken loans of over Rs. 5,000 crores from a consortium led by Andhra Bank which turned into a non-performing asset (NPA) or a bad loan.


    The agency also arrested a former director of Andhra Bank, Anup Prakash Garg, in February.


    They were named as accused in the case by the ED and the CBI. The ED registered a money laundering case in this instance after taking cognisance of an FIR filed earlier by the CBI.


    The CBI had booked Vadodara-based Sterling Biotech, its directors Nitin, Chetan, Dipti, Rajbhushan Omprakash Dixit and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the alleged bank fraud case.


    According to the FIR, the total pending dues of the group of companies were Rs. 5,383 crore as on December 31, 2016

    Andhra Bankbank fraud caseCBI)EDGujaratMoney LaunderingNBWNon-bailable warrantsnon-performing assetNPAPMLAPrevention of Money Laundering ActRs 5000 croresRs. 25 lakhSterling Biotech

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok